Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition.
Michael A WeintraubDazhi LiuRaymond DeMatteoMarcus DaSilva GoncalvesJames H FloryPublished in: Breast cancer research and treatment (2023)
SGLT2 inhibitors are effective treatments for hyperglycemia in the setting of PI3K inhibition.